Automobile License Plate Collectors Association

Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting

Retrieved on: 
Friday, June 2, 2023
Exercise, Drug development, Probability, Therapy, Bank statement, Radisson Blu Hotel Hamburg, AGM, KNRS, CEST, Knowledge, Annual report, Pioglitazone, Proxy, Automobile License Plate Collectors Association, Annual general meeting, Audit, Muthiri kinaru

Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory, and ophthalmic diseases, today published the invitation to the 2023 Annual General Meeting ("AGM"), which will be held at 10 a.m. CEST on Wednesday, June 28, 2023 at the Radisson Blu Hotel Basel, Steinentorstrasse 25, 4051 Basel, Switzerland.

Key Points: 
  • Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory, and ophthalmic diseases, today published the invitation to the 2023 Annual General Meeting ("AGM"), which will be held at 10 a.m. CEST on Wednesday, June 28, 2023 at the Radisson Blu Hotel Basel, Steinentorstrasse 25, 4051 Basel, Switzerland.
  • For information on the agenda items and proposals of the board of directors as well as on how to attend the 2023 Annual General Meeting, exercise voting rights or issue voting instructions to the independent proxy, shareholders can access the invitation to the 2023 Annual General Meeting at https://ir.kinarus.com/2023-agm/ .
  • The 2023 Annual General Meeting will be conducted in English.
  • A record of the resolutions taken by the 2023 Annual General Meeting will be available after the 2023 Annual General Meeting on the Company’s website at https://ir.kinarus.com/2023-agm/ .

Kinarus Therapeutics Publishes Invitation to the 2023 Annual General Meeting

Retrieved on: 
Friday, June 2, 2023
Exercise, Drug development, Probability, Therapy, Bank statement, Radisson Blu Hotel Hamburg, AGM, KNRS, CEST, Knowledge, Annual report, Pioglitazone, Proxy, Automobile License Plate Collectors Association, Annual general meeting, Audit, Muthiri kinaru

Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory, and ophthalmic diseases, today published the invitation to the 2023 Annual General Meeting ("AGM"), which will be held at 10 a.m. CEST on Wednesday, June 28, 2023 at the Radisson Blu Hotel Basel, Steinentorstrasse 25, 4051 Basel, Switzerland.

Key Points: 
  • Kinarus Therapeutics Holding AG (SIX: KNRS) (“Kinarus” or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory, and ophthalmic diseases, today published the invitation to the 2023 Annual General Meeting ("AGM"), which will be held at 10 a.m. CEST on Wednesday, June 28, 2023 at the Radisson Blu Hotel Basel, Steinentorstrasse 25, 4051 Basel, Switzerland.
  • For information on the agenda items and proposals of the board of directors as well as on how to attend the 2023 Annual General Meeting, exercise voting rights or issue voting instructions to the independent proxy, shareholders can access the invitation to the 2023 Annual General Meeting at https://ir.kinarus.com/2023-agm/ .
  • The 2023 Annual General Meeting will be conducted in English.
  • A record of the resolutions taken by the 2023 Annual General Meeting will be available after the 2023 Annual General Meeting on the Company’s website at https://ir.kinarus.com/2023-agm/ .